Gilbert Bensimon
Impact in
Papers in
- Co-authors
- Lucette Lacomblez (19 shared papers)Vincent Meininger (19 shared papers)P. Nigel Leigh (4 shared papers)Philippe Guillet (3 shared papers)P. Nigel Leigh (6 shared papers)Yves Agid (5 shared papers)François Salachas (8 shared papers)Jean‐Sébastien Hulot (2 shared papers)
- Journals
- Human Gene Therapy (6 papers)PLoS ONE (5 papers)Neurology (3 papers)The Lancet (3 papers)Brain (2 papers)
- Partner nations
- FranceUnited KingdomGermany
In The Last Decade
Gilbert Bensimon
46 papers receiving 5.9k citations
Gilbert Bensimon's Hit Papers
Peers
Comparison fields: 5 of 127
- Neurology 3.6k
- Genetics 1.4k
- Neurology 574
- Cellular and Molecular Neuroscience 860
- Pharmacology 626
Countries citing papers authored by Gilbert Bensimon
This map shows the geographic impact of Gilbert Bensimon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilbert Bensimon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilbert Bensimon more than expected).
Fields of papers citing papers by Gilbert Bensimon
This network shows the impact of papers produced by Gilbert Bensimon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilbert Bensimon. The network helps show where Gilbert Bensimon may publish in the future.
Co-authors
The 25 scholars most cited alongside Gilbert Bensimon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis Hit paper breakdown → | 1994 | 1643 |
| 2 | Dose-ranging study of riluzole in amyotrophic lateral sclerosis Hit paper breakdown → | 1996 | 954 |
| 3 | Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study Hit paper breakdown → | 2008 | 681 |
| 4 | 2008 | 239 | |
| 5 | 2002 | 227 | |
| 6 | 1998 | 212 | |
| 7 | 2010 | 209 | |
| 8 | 2018 | 171 | |
| 9 | 1996 | 152 | |
| 10 | 2009 | 142 | |
| 11 | 2002 | 128 | |
| 12 | 2000 | 92 | |
| 13 | 2004 | 89 | |
| 14 | 2000 | 80 | |
| 15 | 2005 | 78 | |
| 16 | 2007 | 70 | |
| 17 | 2012 | 68 | |
| 18 | 1998 | 61 | |
| 19 | 2002 | 60 | |
| 20 | 2011 | 58 |
About Gilbert Bensimon
Gilbert Bensimon is a scholar working on Neurology, Oncology, Genetics, Pharmacology and Genetics, having authored 46 papers that have together received 6.1k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (22 papers), Parkinson's Disease Mechanisms and Treatments (11 papers), Neurogenetic and Muscular Disorders Research (8 papers), CAR-T cell therapy research (6 papers), Virus-based gene therapy research (6 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Alzheimer's disease research and treatments (4 papers) and Herpesvirus Infections and Treatments (4 papers). The work is most often cited by research in Neurology (3.6k citations), Genetics (1.4k citations), Neurology (574 citations), Cellular and Molecular Neuroscience (860 citations) and Pharmacology (626 citations). Gilbert Bensimon has collaborated with scholars based in France, United Kingdom and Germany. Frequent co-authors include Lucette Lacomblez, Vincent Meininger, P. Nigel Leigh, Philippe Guillet, P. Nigel Leigh, Yves Agid, François Salachas, Jean‐Sébastien Hulot, Christine Payan and Farzin Beygui. Their work appears in journals such as Human Gene Therapy, PLoS ONE, Neurology, The Lancet and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.